Insider Transactions in Q3 2022 at Medifast Inc (MED)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 13
2022
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-1.52%
|
$1,240
$124.56 P/Share
|
Aug 09
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
3,940
+48.63%
|
$496,440
$126.17 P/Share
|
Aug 08
2022
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.1%
|
$966
$138.78 P/Share
|
Aug 08
2022
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.23%
|
$966
$138.78 P/Share
|
Aug 08
2022
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.14%
|
$966
$138.78 P/Share
|
Aug 08
2022
|
Constance J. Hallquist |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.1%
|
$1,104
$138.78 P/Share
|
Aug 08
2022
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.38%
|
$1,242
$138.78 P/Share
|
Aug 04
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
399
+1.1%
|
$58,254
$146.01 P/Share
|
Jul 20
2022
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-3.76%
|
$20,010
$174.44 P/Share
|